Published in Ann Oncol on December 01, 2002
Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials. J Clin Oncol (2011) 1.00
Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer. Invest New Drugs (2007) 0.75
Osteopathic medicine: a call for reform. J Am Osteopath Assoc (1993) 7.79
A Ypt/Rab effector complex containing the Sec1 homolog Vps33p is required for homotypic vacuole fusion. Proc Natl Acad Sci U S A (2000) 4.33
Improving surgical resection rate in lung cancer. Thorax (1998) 3.45
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (2000) 2.73
Drosophila dumbfounded: a myoblast attractant essential for fusion. Cell (2000) 2.65
Generation of single-nucleotide repair patches following excision of uracil residues from DNA. Mol Cell Biol (1992) 2.53
Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum. Antimicrob Agents Chemother (2000) 2.49
The crisis in osteopathic medicine. Acad Med (1992) 2.32
Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol (2001) 2.31
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1988) 2.27
Molecular fingerprinting of Mycobacterium tuberculosis and risk factors for tuberculosis transmission in Paris, France, and surrounding area. J Clin Microbiol (1998) 2.17
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Ann Oncol (2002) 2.14
Fibrosing colonopathy in an adult owing to over use of pancreatic enzyme supplements. Gut (2000) 2.10
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer (1993) 2.08
C1 inhibitor deficiency: consensus document. Clin Exp Immunol (2005) 2.07
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer. Ann Oncol (2011) 1.88
SecYEG and SecA are the stoichiometric components of preprotein translocase. J Biol Chem (1995) 1.81
Primary hip replacement prostheses and their evidence base: systematic review of literature. BMJ (2013) 1.69
Sacral neuromodulation in children with urinary and fecal incontinence: a multicenter, open label, randomized, crossover study. J Urol (2010) 1.67
Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut (1994) 1.64
Does reduced length of stay decrease the number of emergency department patients who leave without seeing a physician? J Emerg Med (1997) 1.63
Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules. Clin Oncol (R Coll Radiol) (2005) 1.61
Variants of the Ehlers-Danlos syndrome. Clinical, biochemical, haematological, and chromosomal features of 100 patients. Ann Rheum Dis (1969) 1.59
Biogenesis of the gram-negative bacterial envelope. Cell (1997) 1.49
Interaction of the baculovirus anti-apoptotic protein p35 with caspases. Specificity, kinetics, and characterization of the caspase/p35 complex. Biochemistry (1998) 1.48
Should thyroid function be assessed before cardiopulmonary bypass operations? Ann Thorac Surg (1994) 1.48
Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials. Eur J Cancer (2010) 1.47
Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut (1992) 1.47
The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model. Health Technol Assess (2007) 1.46
Massage therapy is associated with enhancement of the immune system's cytotoxic capacity. Int J Neurosci (1996) 1.45
Long-term survival in patients with non-small cell lung cancer treated with palliative radiotherapy. Clin Oncol (R Coll Radiol) (2001) 1.43
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation. Health Technol Assess (2008) 1.41
Optimization of chemically defined cell culture media--replacing fetal bovine serum in mammalian in vitro methods. Toxicol In Vitro (2010) 1.39
[Recommendations on the therapy of bronchial carcinoma]. Pneumologie (2002) 1.39
Concurrent chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the oesophagus: a single centre experience. Ann Acad Med Singapore (2005) 1.38
Multicenter study of a commercial, automated polymerase chain reaction system for the rapid detection of Mycobacterium tuberculosis in respiratory specimens in routine clinical practice. Eur J Clin Microbiol Infect Dis (2001) 1.37
The effectiveness and cost-effectiveness of behavioural interventions for the prevention of sexually transmitted infections in young people aged 13-19: a systematic review and economic evaluation. Health Technol Assess (2010) 1.37
A new role for a SNARE protein as a regulator of the Ypt7/Rab-dependent stage of docking. Proc Natl Acad Sci U S A (2000) 1.35
Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J Clin Microbiol (1996) 1.35
The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model. Health Technol Assess (2009) 1.35
Quality of response in different population groups in mail and telephone surveys. Am J Epidemiol (1984) 1.34
Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer. J Clin Oncol (2001) 1.32
Design of a prognostic index score for metastatic nasopharyngeal carcinoma. Eur J Cancer (2003) 1.29
Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol (Oxf) (1997) 1.29
Phase I pharmacokinetic study of a weekly liposomal paclitaxel formulation (Genexol-PM) in patients with solid tumors. Ann Oncol (2009) 1.27
Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation. Health Technol Assess (2004) 1.27
Meiotic instability of human minisatellite CEB1 in yeast requires DNA double-strand breaks. Nat Genet (1999) 1.26
A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors. Cell (1991) 1.25
Interpretation of patient-reported outcomes for hip and knee replacement surgery: identification of thresholds associated with satisfaction with surgery. J Bone Joint Surg Br (2012) 1.22
Survival, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patients. Br J Radiol (1993) 1.22
Intestinal permeability in patients with coeliac disease and dermatitis herpetiformis. Gut (1985) 1.22
Cystic rectal duplication: a rare cause of neonatal intestinal obstruction. Pediatr Surg Int (1997) 1.22
Efficient transmission of two different sheep scrapie isolates in transgenic mice expressing the ovine PrP gene. J Virol (2001) 1.21
A catalytic cycle for the asymmetric synthesis of epoxides using sulfur ylides. J Org Chem (2001) 1.21
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. Health Technol Assess (2006) 1.21
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess (2007) 1.21
Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis (1998) 1.19
Direction of weight change in recurrent depression. Consistency across episodes. Arch Gen Psychiatry (1990) 1.17
Interferon alpha (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation. Health Technol Assess (2007) 1.15
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer. Ann Oncol (2011) 1.15
Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer. Br J Cancer (2008) 1.14
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia. Leukemia (2012) 1.14
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma. Ann Oncol (2005) 1.14
Prognostic value of tumour thickness in cutaneous malignant melanoma. J Clin Pathol (1983) 1.13
A posterior arthroscopic approach to bullet extraction from the hip. J Trauma (1987) 1.12
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Health Technol Assess (2007) 1.12
Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart (1998) 1.09
Quantitative immunolocalization of a P29 protein (GRA7), a new antigen of toxoplasma gondii. J Histochem Cytochem (1998) 1.08
Value of specific immunoglobulin A detection by two immunocapture assays in the diagnosis of toxoplasmosis. Eur J Clin Microbiol Infect Dis (1995) 1.08
Training in advanced trauma life support. BMJ (1998) 1.08
Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type. Ann Oncol (2002) 1.08
Tracheobronchial ruptures from blunt thoracic trauma in children. J Pediatr Surg (1999) 1.07
Extramedullary plasmacytoma of the rectum: two cases treated by radiotherapy. Clin Radiol (1987) 1.07
Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial. Br J Cancer (2006) 1.07
Genetic characterization of Toxoplasma gondii from wild boar (Sus scrofa) in France. Vet Parasitol (2009) 1.07
Interpretation of cortisol response to synacthen. Ann Clin Biochem (1996) 1.06
Nosocomial infection with highly resistant, Proteus rettgeri. Report of an epidemic. Am J Epidemiol (1976) 1.06
Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis. Health Technol Assess (2004) 1.05
Incidence of IDDM in Montreal by ethnic group and by social class and comparisons with ethnic groups living elsewhere. Diabetes (1988) 1.05
Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol (2001) 1.04
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation. Health Technol Assess (2006) 1.04
Eosinophils in acute renal allograft rejection. Transpl Immunol (1994) 1.04
In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine (Phila Pa 1976) (1994) 1.02
Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, pemetrexed disodium, ALIMTA) and cisplatin: a multicenter phase II trial. Ann Oncol (2000) 1.00
Detection of Cryptosporidium parvum DNA in formed human feces by a sensitive PCR-based assay including uracil-N-glycosylase inactivation. J Clin Microbiol (1997) 1.00
Propionibacterium acnes endocarditis in a native valve complicated by intraventricular abscess: a case report and review. Scand J Infect Dis (2001) 1.00
The cost-effectiveness of testing for hepatitis C in former injecting drug users. Health Technol Assess (2006) 1.00
Importance of 3' non-coding sequences for efficient retrovirus-mediated gene transfer in avian cells revealed by self-inactivating vectors. J Gen Virol (1993) 1.00
Cationic corticosteroid for nonviral gene delivery. Gene Ther (2004) 0.99
The effectiveness and cost-effectiveness of microwave and thermal balloon endometrial ablation for heavy menstrual bleeding: a systematic review and economic modelling. Health Technol Assess (2004) 0.99
Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy. Eur Respir J (2006) 0.99
Aetiology and outcomes of adult superior oblique palsies: a modern series. Eye (Lond) (2008) 0.97
Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicals. Front Neuroeng (2011) 0.97
Utility of admission cardiac troponin and "Ischemia Modified Albumin" measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J (2006) 0.97
PCR for diagnosis and follow-up of two cases of disseminated toxoplasmosis after kidney grafting. J Clin Microbiol (1996) 0.97
Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients. J Clin Microbiol (1995) 0.96
The use of arthrocentesis for the treatment of osteoarthritic temporomandibular joints. J Oral Maxillofac Surg (2001) 0.95